Atypical choroid plexus papilloma treated with single agent bevacizumab.

Kamar, Francois G; Kairouz, Victor F; Nasser, Selim M; Faddoul, Sami G; Saikali, Ibrahim C

Kamar, Francois G; Kairouz, Victor F; Nasser, Selim M; Faddoul, Sami G; Saikali, Ibrahim C.

Afiliação

Kamar FG; Division of Hematology and Oncology, Clemenceau Medical Center , Beirut, Lebanon, USA ; Lebanese American University, School of Medicine , Byblos, Lebanon, USA.
Kairouz VF; Buffalo University , New York, NY, USA.
Nasser SM; Division of Hematology and Oncology, Clemenceau Medical Center , Beirut, Lebanon, USA ; Lebanese American University, School of Medicine , Byblos, Lebanon, USA.
Faddoul SG; Columbia University College of Physician and Surgeons , New York, NY, USA.
Saikali IC; Division of Hematology and Oncology, Clemenceau Medical Center , Beirut, Lebanon, USA ; Lebanese American University, School of Medicine , Byblos, Lebanon, USA.

Rare Tumors ; 6(1): 4687, 2014 Jan 23.

Article em En | MEDLINE | ID: mdl-24711901

Palavras-chave

antiangiogenic; bevacizumab; chemotherapy; choroid plexus papilloma; malignant

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: Rare Tumors Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google